Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
September 6, 2022
Homology Medicines Appoints Albert Seymour, Ph.D., Chief Executive Officer
September 6, 2022
IDEAYA Announces First-Patient-In for Phase I Clinical Trial to Evaluate Darovasertib Monotherapy in (Neo)Adjuvant Uveal Melanoma
September 6, 2022
New Long-Term Safety and Efficacy Data Presented with Paltusotine in Participants Living With Acromegaly
September 2, 2022
South Carolina Department of Corrections and Pear Therapeutics Team Up to Support Inmates in Recovery from Substance Use Disorders
August 29, 2022
Cabaletta Bio to Present Data at the 31st EADV Congress and Provides Update on DesCAARTes™ Trial
August 29, 2022
IDEAYA Announces Achievement of First Milestone in Ongoing Collaboration with GSK for Potential First-in-Class Pol Theta Helicase Inhibitor Development Candidate
August 22, 2022
CinCor Pharma Announces Presentation of Phase 1 Clinical Data for Baxdrostat at the Upcoming European Society of Cardiology 2022 Congress
August 22, 2022
Arvinas Announces Changes to its Board of Directors
August 18, 2022
Arvinas Appoints Lisa Sinclair as Senior Vice President, Corporate Operations
August 16, 2022
CinCor Pharma Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
« Previous Page
1
…
7
8
9
10
11
…
103